Drug prices are an area ripe for reform, as 90% of employers say they represent a significant threat to affordability.
The COVID-19 pandemic hasn't yet had an impact on employers' health plan strategies, according to a survey by the National Alliance of Healthcare Purchaser Coalitions. The report found 61% of employers will continue with their current strategy in 2021, and 10% are accelerating their strategy. Looking farther ahead, 55% of employers expect to maintain their strategy in 2022, and 8% anticipate acceleration.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.